Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Hold
4,700
0.27% 79
2026
Q1
$1.65M Hold
4,700
0.24% 85
2025
Q4
$1.54M Hold
4,700
0.25% 97
2025
Q3
$1.4M Hold
4,700
0.21% 97
2025
Q2
$1.37M Hold
4,700
0.23% 94
2025
Q1
$1.44M Buy
+4,700
New +$1.39M 0.19% 94
2024
Q2
Sell
-1,400
Closed -$396K 160
2024
Q1
$396K Sell
1,400
-154
-10% -$45.1K 0.07% 79
2023
Q4
$462K Sell
1,554
-698
-31% -$190K 0.08% 96
2023
Q3
$600K Buy
2,252
+58
+3% +$14.5K 0.19% 74
2023
Q2
$494K Buy
2,194
+196
+10% +$45.5K 0.12% 66
2023
Q1
$488K Sell
1,998
-252
-11% -$61.9K 0.17% 67
2022
Q4
$589K Sell
2,250
-8,091
-78% -$2.17M 0.25% 56
2022
Q3
$2.38M Buy
10,341
+7,616
+279% +$1.85M 1.22% 7
2022
Q2
$663K Buy
2,725
+700
+35% +$172K 0.17% 67
2022
Q1
$492K Buy
2,025
+208
+11% +$47.8K 0.04% 89
2021
Q4
$412K Sell
1,817
-150
-8% -$31.7K 0.04% 115
2021
Q3
$421K Buy
1,967
+247
+14% +$56.9K 0.06% 90
2021
Q2
$425K Sell
1,720
-105
-6% -$25.8K 0.04% 106
2021
Q1
$455K Sell
1,825
-3,012
-62% -$719K 0.06% 87
2020
Q4
$1.1M Buy
4,837
+3,285
+212% +$757K 0.2% 60
2020
Q3
$394K Buy
1,552
+543
+54% +$135K 0.08% 56
2020
Q2
$257K Buy
+1,009
New +$230K 0.07% 62
2020
Q1
Sell
-1,558
Closed -$376K 128
2019
Q4
$376K Buy
+1,558
New +$343K 0.1% 63
2019
Q3
Sell
-163
Closed -$30K 213
2019
Q2
$30K Buy
+163
New +$29.2K 0.01% 162
2018
Q3
Sell
-104
Closed -$19K 184
2018
Q2
$19K Buy
+104
New +$18.4K 0.01% 185

Other funds holding AMGN

Advisors Preferred's AMGN Position: Q2 2026 in Review

Advisors Preferred held its Amgen (AMGN) position steady in Q2 2026 at 4,700 shares worth $1.76M. The position accounts for 0.27% of the portfolio, ranked #79.

Advisors Preferred first reported a position in AMGN in Q2 2018 and has held it in 25 quarters since. The position peaked at $2.38M in Q3 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advisors Preferred held 4,700 shares of Amgen worth $1.76M as of Q2 2026.
  • Advisors Preferred left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.27% of Advisors Preferred's portfolio in Q2 2026, its #79 holding.
  • Advisors Preferred first reported a position in Amgen in Q2 2018 and has held it in 25 quarters since.
  • Advisors Preferred's Amgen position peaked at $2.38M in Q3 2022.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.